DYN Dynegy Inc.

Dynegy Lenders Agree to Reprice and Upsize Its Term Loan C

Dynegy Inc. (NYSE: DYN) will reprice its $2 billion Term Loan C, which will be incurred in connection with the pending ENGIE portfolio acquisition. The Company will also upsize the term loan by $224 million to refinance its existing Term Loan B due in 2020 and extend the maturity in respect thereof.

The transaction will reduce the interest rate margin on the term loan by 75 basis points to LIBOR +325 basis points. The LIBOR floor remains at 1.00%.

As a result, the Company expects interest savings over the life of the loan, which will mature seven years from the closing of the ENGIE acquisition, to total approximately $100 million. Expected interest savings in 2017 are estimated to be approximately $14 million.

The repricing will close substantially concurrently with, or promptly after, the ENGIE acquisition closing.

ABOUT DYNEGY

At Dynegy, we generate more than just power for our customers. We are committed to being a leader in the electricity sector. Throughout the Midwest and Northeast, Dynegy operates power generating facilities capable of producing more than 22,000 megawatts of electricity—or enough energy to power about 18 million American homes. We’re proud of what we do, but it’s about much more than just output. We’re always striving to generate power safely and responsibly for our wholesale and retail electricity customers who depend on that energy to grow and thrive.

FORWARD-LOOKING STATEMENT

This news release contains statements reflecting assumptions, expectations, projections, intentions or beliefs about future events that are intended as “forward-looking statements,” particularly those statements concerning Dynegy’s expectations regarding interest savings, expenses and timing of closing. Discussion of risks and uncertainties that could cause actual results to differ materially from current projections, forecasts, estimates and expectations of Dynegy is contained in Dynegy’s filings with the Securities and Exchange Commission (the SEC). Specifically, Dynegy makes reference to, and incorporates herein by reference, the sections entitled “Risk Factors” in its 2015 Form 10-K and subsequent Forms 10-Q. In addition to the risks and uncertainties set forth in Dynegy’s SEC filings, the forward-looking statements described in this press release could be affected by the following, among other things, (i) the repricing may involve unexpected costs or unexpected liabilities; and (ii) conditions to the closing of the ENGIE acquisition may not be satisfied. Any or all of Dynegy’s forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks, uncertainties and other factors, many of which are beyond Dynegy’s control.

EN
17/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dynegy Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 15, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dyne Therapeutics Inc: 1 director

A director at Dyne Therapeutics Inc bought 100,000 shares at 9.110USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch